We report here the identification and optimization of a novel series of potent GlyT1 inhibitors. A ligand design campaign that utilized known GlyT1 inhibitors as starting points led to the identification of a novel series of pyrrolo[3,4- c]pyrazoles amides (21-50) with good in vitro potency. Subsequent optimization of physicochemical and in vitro ADME properties produced several compounds with promising pharmacokinetic profiles.
View Article and Find Full Text PDFThe synthesis and characterization of several Cr(III) complexes of the constrained macrocyclic ligand 1,4-C(2)-cyclam = 1,4,8,11-tetraazabicyclo[10.2.2]hexadecane is reported.
View Article and Find Full Text PDF